STOCK TITAN
  1. Home
  2. Sec-filings
  3. AHR
  4. [Form 4] American Healthcare REIT, Inc. Insider Trading Activity

[Form 4] American Healthcare REIT, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

American Healthcare REIT, Inc. (AHR) – Form 4 insider filing

Director Dianne Hurley received 3,042 restricted shares of AHR common stock on 25 Jun 2025 upon her re-election to the board. The grant was recorded at $0 cost and will vest on 25 Jun 2026. Following this award, Hurley’s direct beneficial ownership increased to 31,443 shares. No shares were sold or transferred, and no derivative securities were involved. The transaction was coded “A,” indicating a stock award rather than an open-market purchase or sale.

The filing reflects routine board compensation, resulting in minor dilution and a modest increase in insider ownership.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine board equity grant; strengthens alignment but immaterial to valuation.

The Form 4 discloses a standard annual equity grant to Director Dianne Hurley. Grant size (3,042 shares) is small relative to AHR’s outstanding share count and represents <1% of Hurley’s post-grant holdings. Such awards are common in REIT governance structures to align directors with shareholder interests. Because the shares vest over one year, they encourage short-term engagement rather than long-term retention. There is no cash outflow and negligible dilution. From a governance standpoint, this signals continued board participation but carries no material financial impact.

TL;DR: Insider award positive sentiment, but size too small to move the stock.

Insider activity that involves acquiring, not selling, is directionally encouraging. However, 3,042 shares is unlikely to affect float or insider ownership meaningfully. The award price of $0 confirms it is compensation, not a market purchase, so it gives limited new information about management’s valuation view. I categorize the filing as not impactful for portfolio decisions unless aggregated with broader insider trends.

Insider Hurley Dianne
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 3,042 $0.00 $0.00
Holdings After Transaction: Common Stock — 31,443 shares (Direct)
Footnotes (1)
  1. F1. Upon her re-election as a director to the board of directors of the Issuer on June 25, 2025, the Reporting Person was granted 3,042 shares of restricted common stock on June 25, 2025. The reported shares of restricted common stock vest on June 25, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hurley Dianne
(Last) (First) (Middle)
C/O AMERICAN HEALTHCARE REIT, INC.
18191 VON KARMAN AVE., STE. 300
(Street)
IRVINE CA 92612
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/25/2025 A 3,042(1) A $0 31,443 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Upon her re-election as a director to the board of directors of the Issuer on June 25, 2025, the Reporting Person was granted 3,042 shares of restricted common stock on June 25, 2025. The reported shares of restricted common stock vest on June 25, 2026.
Remarks:
/s/ DIANNE HURLEY 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR